Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q4 EPS of ($0.29), $0.07 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.05 million versus the consensus estimate of $1.67 million.

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.